Keyphrases
Sialadenitis
100%
Hypoglossal Nerve Stimulation
50%
Post-tonsillectomy Hemorrhage
50%
Quality of Life
50%
Body Mass Index
50%
Supine Sleep
50%
Young children
50%
Serum Biomarkers
50%
Preschool children
50%
Mild Traumatic Brain Injury (mTBI)
50%
Unknown Etiology
50%
Postsurgical Pain
50%
Randomized Clinical Trial
50%
Gabapentin
50%
Head-and-neck
50%
Salivary Gland
43%
Hearing Impairment
37%
Treatment Response
35%
Glial Fibrillary Acidic Protein
26%
Audiology
25%
Parent-proxy
25%
Childhood Hearing Loss
25%
Permanent Hearing Loss
25%
Older children
25%
7-year-olds
25%
Schools for the Deaf
25%
Apnea-hypopnea Index
25%
Placebo Groups
22%
Clinically Significant
21%
UCHL1
20%
Obstructive Sleep Apnea
20%
Between-group
19%
S100
17%
Sclerosing Polycystic Adenosis
16%
Kimura Disease
16%
Juvenile Recurrent Parotitis
16%
Deposition Disorder
16%
Autoimmunity
16%
Self-limiting
16%
Refractory Cases
16%
Malignancy
16%
Presentation Evaluation
16%
Etiology
16%
Pathological Diagnosis
16%
Sialendoscopy
16%
Inflammatory Pseudotumor
16%
Surgical Excision
16%
Parotid Salivary Gland
16%
Rare Processes
16%
Amyloidosis
16%
Medicine and Dentistry
Sialadenitis
100%
Salivary Gland
60%
Infection
56%
Bleeding
50%
Hypoglossal Nerve
50%
Neurostimulation
50%
Body Mass Index
50%
Tonsillectomy
50%
Gabapentin
50%
Quality of Life
50%
Neck
50%
Hearing Impairment
50%
Randomized Clinical Trial
50%
Case-Control Study
50%
Placebo
38%
Treatment Response
33%
Diseases
33%
Obstruction
26%
Parotitis
26%
Obstructive Sleep Apnea
20%
Hypopnea
20%
Apnea
20%
Angiolymphoid Hyperplasia with Eosinophilia
16%
Autoimmunity
16%
Amyloidosis
16%
Cancer
16%
Systemic Disease
16%
Neoplasm
16%
School-Age Children
16%
Rosai-Dorfman Disease
16%
Immune Response
16%
Plasma Cell Granuloma
16%
Adenosis
16%
Lymphoproliferative Disease
16%
Biopsy Technique
16%
Audiology
14%
Morphine
11%
Visual Analog Scale
11%
Patient Satisfaction
11%
Adverse Effect
11%
Mumps Virus
10%
Actinomyces
10%
Antibiotic Therapy
10%
Salivation
10%
Physical Disease by Body Function
10%
Pathogen
10%
Persistent Infection
10%
Mycobacteria
10%
Virus
10%
Stimulation Therapy
8%
